CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling

Zhao Liu; Mi Chen; Lin-Ka Xie; Ting Liu; Zhen-Wei Zou; Yong Li; Peng Chen; Xin Peng; Charlie Ma; Wen-Jie Zhang; Pin-Dong Li

doi:doi:10.18632/aging.101571

← Back

Research Paper Volume 10, Issue 10 pp 2570—2584

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling

Figure 2. The effect of CLCA4 expression on overall survival and time to recurrence is shown for patients with HCC. All patients were classified according to tumor size, vascular invasion, TNM stage and BCLC stage. Kaplan-Meier survival estimates and log-rank tests were used to analyze the prognostic value of CLCA4 expression in all patients (A) and each subgroup (B-I).